Partnership Opportunities Melanoma Institute Australia has a track record of forming strategic partnerships with companies like RingCentral, La Roche-Posay, and Toyota Material Handling Australia. This indicates potential collaboration and sales opportunities for businesses operating in related sectors.
Award Recognition Being recognized as joint Australians of the Year in 2024 highlights the prestige and reputation of Melanoma Institute Australia. Leveraging this recognition in sales pitches can enhance credibility and trust among prospective clients and partners.
Innovative Vaccine Development Melanoma Institute Australia's development of personalized vaccines showcases their innovative approach to melanoma treatment. This opens up possibilities for collaborations with pharmaceutical companies or healthcare institutions interested in cutting-edge therapies.
Clinicopathologic Model Launch The launch of a predictive model based on clinicopathologic factors demonstrates Melanoma Institute Australia's commitment to advancements in melanoma care. Businesses focusing on healthcare technology or data analysis could explore partnerships to leverage this model.
Immunotherapy Availability The availability of combined immunotherapy ipilimumab and nivolumab on the Pharmaceutical Benefits Scheme presents sales opportunities for pharmaceutical companies targeting advanced melanoma patients. Collaborating with Melanoma Institute Australia could help reach a broader patient base.
$50M$100M
$10M
$10M
$10M
$10M
$10MMelanoma Institute Australia uses 8 technology products and services including 33Across, AdRoll CMP System, Shopify, and more. Explore Melanoma Institute Australia's tech stack below.
| Melanoma Institute Australia Email Formats | Percentage |
| First.Last@melanoma.org.au | 87% |
| FLast@melanoma.org.au | 10% |
| FirstLast@melanoma.org.au | 2% |
| First.L@melanoma.org.au | 1% |
Research ServicesNew South Wales, Australia51-200 Employees
Melanoma Institute Australia (MIA) is a non-profit organisation dedicated to reaching zero deaths from melanoma this decade through innovative, world-class research, treatment and education. Based in the Poche Centre, the world’s largest melanoma research and treatment centre, MIA is affiliated with The University of Sydney and St Vincent’s and Mater Health Sydney.
Company Overview
Funding & FinancialsMelanoma Institute Australia's revenue is in the range of $10M$50M
Funding & FinancialsMelanoma Institute Australia's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com